Search for: "Teva Pharmaceuticals, Inc."
Results 41 - 60
of 838
Sorted by Relevance
|
Sort by Date
24 Jun 2015, 9:59 pm
Teva Pharmaceuticals USA, Inc. [read post]
11 Sep 2020, 7:06 am
The U.S. government filed a False Claims Act case against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]
26 Aug 2012, 9:34 pm
Teva. [read post]
19 Jan 2010, 1:05 pm
Pfizer Inc. has filed a civil suit against the generic drug manufacturer Teva Pharmaceutical Industries Ltd. for infringement of US patent for antibiotic drug Zyvox. [read post]
9 Jan 2017, 9:36 am
In other words, Copaxone should remain a $4 billion drug, annually.link to Pantagraph: http://www.pantagraph.com/business/investment/markets-and-stocks/factors-that-sent-teva-pharmaceutical-industries-ltd-sliding-in/article_74234eee-a5ec-5c58-a54b-82597151b1e6.htmlPatents covering "three per week" dosing were not at issue in the Supreme Court case of Teva Pharmaceuticals USA, Inc. v. [read post]
9 Apr 2014, 9:59 pm
Watson Pharmaceuticals, Inc., which doesn't... [read post]
7 Dec 2021, 8:33 am
Inc. v. [read post]
16 Sep 2013, 9:59 pm
Teva Pharmaceuticals USA. [read post]
26 Nov 2007, 9:02 pm
By Baltazar Gomez -- Last month, Astellas Pharma Inc., King Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. announced that U.S. subsidiaries of Astellas, along with Item Development AB and King have signed settlement agreements with respect to U.S. [read post]
26 Jan 2010, 9:59 pm
Teva Pharmaceuticals USA, Inc., Proctor & Gamble Co. v. [read post]
13 Oct 2014, 8:46 pm
Teva Pharmaceuticals USA, Inc. et al. v. [read post]
17 Apr 2014, 12:49 pm
Teva Pharmaceuticals USA, Inc., the maker of a widely used drug for treating multiple sclerosis, told the Supreme Court on Thursday that it is willing to put aside promptly up to $500 million to cover marketing losses that generic competitors might have if Teva succeeds in keeping them on the sidelines for months with their lower-priced alternative versions of the drug. [read post]
22 Jul 2018, 8:32 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
17 Oct 2018, 7:49 pm
The Federal Circuit found the district court committed no error in construing claim terms as non-limiting for nonobviousness purposes or in invalidating as obvious all asserted claims of the Copaxone patents, including a 40-milligram dosage three times per week (Teva Pharmaceuticals USA, Inc. v. [read post]
26 Aug 2009, 9:59 pm
Plaintiff-Appellant Ortho-McNeil Pharmaceutical, Inc. owns the '221 patent, which relates to a tramadol and acetaminophen composition for use in prescription pain relief. [read post]
19 Jan 2009, 2:56 pm
Teva and its wholly owned subsidiary Ivax Pharmaceuticals Inc. comprise two of the thirteen drug manufacturers sued by Massachusetts in 2003. [read post]
26 Jun 2018, 8:17 am
Teva Pharmaceuticals USA, Inc. [read post]
11 Mar 2014, 9:09 pm
On March 11, the Department of Justice announced that Teva Pharmaceuticals, Inc., and its subsidiary, Ivax, paid kickbacks to an Illinois doctor to induce him to prescribe their generic antipsychotic, Clozapine. [read post]
22 Jan 2019, 9:50 pm
Teva. [read post]
20 Aug 2009, 12:52 am
Following a bench trial concerning Merck's Singulair ® patent, the court rejected Teva Pharmaceutical's validity and unenforceability defenses and concluded that Teva's ANDA applications infringed the patent-in-suit. [read post]
